Stocks in news:
Zydus: The company has partnered with Medicure to launch its NDA Product, ZYPITAMAG (pitavastatin) in the US. The drug is used to treat cholesterol levels.
Ashoka Buildcon: Wins orders worth Rs 2,991.7 crore for NHAI projects
Fortis Healthcare: Non-Executive Independent Director Joji Sekhon Gill Resigns From Co Effective March 7
IDFC Bank: Raises MCLR By 15-25 bps across all tenors
Bharti Airtel: National Company Law Tribunal grants nod to Bharti-Telenor merger
4 stocks under ban period on NSE
Security in ban period for the next trade date under the F&O segment includes companies in which the security has crossed 95 percent of the market-wide position limit.
Securities which are banned for trading include names such as Balrampur Chini, DHFL, HDIL, and IDBI Bank.
No comments:
Post a Comment